News
Samsung Bioepis has entered into a license, development and commercialization agreement with Harrow for its ophthalmology ...
Current CEO Didier Dargent will transition to Executive Chairman.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback